What is the current annual D&A of EXEL?

As of today, EXEL annual D&A is $29.06M

What is 1-year change in EXEL annual D&A?

EXEL annual D&A is up +0.87% year-over-year

What is 3-year change in EXEL annual D&A?

EXEL annual D&A is up +39.19% over the past 3 years

How far is EXEL annual D&A from its all-time high?

EXEL annual D&A is currently at its all-time high

How does EXEL annual D&A rank versus sector peers?

EXEL annual D&A is higher than 81.30% of companies in Healthcare sector

When is EXEL next annual earnings release?

As of today, the next annual earnings release for EXEL has not been scheduled

What is the current quarterly D&A of EXEL?

As of today, EXEL quarterly D&A is $6.98M

What is EXEL quarterly D&A most recent change?

EXEL quarterly D&A was up +0.52% on June 1, 2026

What is 1-year change in EXEL quarterly D&A?

EXEL quarterly D&A is down -4.88% year-over-year

How far is EXEL quarterly D&A from its all-time high?

EXEL quarterly D&A is currently -48.59% below its historical high of $13.59M set on March 31, 2023

How does EXEL quarterly D&A rank versus sector peers?

EXEL quarterly D&A is higher than 78.80% of companies in Healthcare sector

When is EXEL next earnings release?

The next earnings release for EXEL is on October 27, 2026

What is the current TTM D&A of EXEL?

As of today, EXEL TTM D&A is $28.30M

What is EXEL TTM D&A most recent change?

EXEL TTM D&A was down -1.25% on June 1, 2026

What is 1-year change in EXEL TTM D&A?

EXEL TTM D&A is down -4.98% year-over-year

How far is EXEL TTM D&A from its all-time high?

EXEL TTM D&A is currently -11.68% below its historical high of $32.04M set on June 30, 2023

How does EXEL TTM D&A rank versus sector peers?

EXEL TTM D&A is higher than 79.31% of companies in Healthcare sector

When is EXEL next earnings release?

The next earnings release for EXEL is on October 27, 2026

Exelixis, Inc. (EXEL) Depreciation And Amortization History & Chart

Annual D&A

$29.06M$252.00K+0.87%

December 1, 2025

Summary

Current Value: As of today, EXEL annual D&A is $29.06M, up +0.87% on December 1, 2025
Historical Performance: EXEL annual D&A is up +39.19% over the past 3 years, up +107.97% over the past 5 years
All-Time High Comparison: EXEL annual D&A is currently at its all-time high
3-Year Low Comparison: EXEL annual D&A is +39.19% above its 3-year low of $20.88M reached on an earlier date
Sector Comparison: EXEL annual D&A is higher than 81.30% of companies in Healthcare sector

Depreciation & Amortization Chart

beforeafter

Performance

EXEL Performance
Metric	Date	Value	1Y	3Y	5Y	15Y
	Dec 1, 25	$29.06M	+0.9%	+39.2%	+108.0%	+175.6%
	Jun 1, 26	$6.98M	-4.9%	-47.5%	+38.8%	+249.2%
	Jun 1, 26	$28.30M	-5.0%	-11.7%	+69.5%	+229.1%
Price	Sep 17, 26	$58.49	+44.6%	+174.0%	+182.3%	+746.5%
	Dec 1, 25	$0.00	-100.0%	-100.0%	-100.0%	-100.0%
	Dec 1, 25	$1.54B	-6.7%	+7.6%	+75.6%	+454.3%
	Dec 1, 25	$1.34B	-4.2%	-0.6%	+59.7%	+2191.0%
Annual Revenue	Dec 1, 25	$2.32B	+7.0%	+44.0%	+134.9%	+1153.8%

Depreciation & Amortization Highs

EXEL Annual D&A Highs Comparison
Period	High	Date	Current
3Y	$29.06M	Dec 1, 25	at high
5Y	$29.06M	Dec 1, 25	at high
All	$29.06M	Dec 1, 25	at high

Depreciation & Amortization Lows

EXEL Annual D&A Lows Comparison
Period	Low	Date	Current
3Y	$20.88M	N/A	+39.2%
5Y	$13.97M	N/A	+108.0%
All	$731.00K	Dec 1, 97	+3874.7%

Depreciation & Amortization History

Year	Value	Change
2025	$29.06M	+0.9%
2024	$28.80M	+12.0%
2023	$25.72M	+23.2%
2022	$20.88M	+10.1%
2021	$18.96M	+35.7%
2020	$13.97M	+25.1%
2019	$11.17M	+43.7%
2018	$7.77M	+554.5%
2017	$1.19M	+18.5%
2016	$1.00M	-28.7%
2015	$1.41M	-41.2%
2014	$2.39M	-24.0%
2013	$3.15M	-45.0%
2012	$5.72M	-16.2%
2011	$6.82M	-35.3%

Year	Value	Change
2010	$10.54M	-16.3%
2009	$12.60M	-4.8%
2008	$13.23M	+16.7%
2007	$11.33M	-33.0%
2006	$16.91M	-4.8%
2005	$17.76M	+1.5%
2004	$17.49M	-1.4%
2003	$17.75M	+6.2%
2002	$16.70M	+9.8%
2001	$15.21M	+214.5%
2000	$4.84M	+123.2%
1999	$2.17M	+41.7%
1998	$1.53M	+109.2%
1997	$731.00K	-

FAQ

What is the current annual D&A of EXEL?: As of today, EXEL annual D&A is $29.06M
What is 1-year change in EXEL annual D&A?: EXEL annual D&A is up +0.87% year-over-year
What is 3-year change in EXEL annual D&A?: EXEL annual D&A is up +39.19% over the past 3 years
How far is EXEL annual D&A from its all-time high?: EXEL annual D&A is currently at its all-time high
How does EXEL annual D&A rank versus sector peers?: EXEL annual D&A is higher than 81.30% of companies in Healthcare sector
When is EXEL next annual earnings release?: As of today, the next annual earnings release for EXEL has not been scheduled

Quarterly D&A

$6.98M$36.00K+0.52%

June 1, 2026

Summary

Current Value: As of today, EXEL quarterly D&A is $6.98M, up +0.52% on June 1, 2026
Historical Performance: EXEL quarterly D&A is down -4.88% year-over-year, down -47.45% over the past 3 years
All-Time High Comparison: EXEL quarterly D&A is currently -48.59% below its historical high of $13.59M set on March 31, 2023
3-Year Low Comparison: EXEL quarterly D&A is +190.89% above its 3-year low of -$7.68M reached on September 29, 2023
Sector Comparison: EXEL quarterly D&A is higher than 78.80% of companies in Healthcare sector

Performance

EXEL Performance
Metric	Date	Value	3M	1Y	3Y	5Y
	Jun 1, 26	$6.98M	+0.5%	-4.9%	-47.5%	+38.8%
	Dec 1, 25	$29.06M	–	+0.9%	+39.2%	+108.0%
	Jun 1, 26	$28.30M	-1.3%	-5.0%	-11.7%	+69.5%
Price	Sep 17, 26	$58.49	+12.7%	+44.6%	+174.0%	+182.3%
	Jun 1, 26	$0.00	-100.0%	-100.0%	-100.0%	-100.0%
	Jun 1, 26	$416.64M	+4.1%	+8.7%	+7.2%	+44.1%
	Jun 1, 26	$359.62M	+5.9%	+7.3%	-3.9%	+45.4%
Quarterly Revenue	Jun 1, 26	$628.69M	+2.9%	+10.6%	+33.8%	+63.2%

Quarterly D&A Highs

EXEL Quarterly D&A Highs Comparison
Period	High	Date	Current
1Y	$7.42M	N/A	-5.9%
3Y	$13.29M	N/A	-47.5%
5Y	$13.59M	Mar 31, 23	-48.6%
All	$13.59M	Mar 31, 23	-48.6%

Quarterly D&A Lows

EXEL Quarterly D&A Lows Comparison
Period	Low	Date	Current
1Y	$6.95M	Dec 1, 25	+0.6%
3Y	-$7.68M	Sep 29, 23	+190.9%
5Y	-$7.68M	Sep 29, 23	+190.9%
All	-$7.68M	Sep 29, 23	+190.9%

Quarterly D&A History

Month	Value	Change
Jun 2026	$6.98M	+0.5%
Mar 2026	$6.95M	+0.0%
Dec 2025	$6.95M	-6.4%
Sep 2025	$7.42M	+1.1%
Jun 2025	$7.34M	-0.0%
Mar 2025	$7.35M	-3.9%
Dec 2024	$7.64M	+2.5%
Sep 2024	$7.45M	+1.7%
Jun 2024	$7.33M	+14.9%
Mar 2024	$6.38M	-2.3%
Dec 2023	$6.53M	+184.9%
Sep 2023	-$7.68M	-157.8%
Jun 2023	$13.29M	-2.2%
Mar 2023	$13.59M	+327.0%
Dec 2022	-$5.99M	-153.7%
Sep 2022	$11.15M	+13.4%
Jun 2022	$9.83M	+67.4%
Mar 2022	$5.88M	+77.4%
Dec 2021	$3.31M	-46.3%
Sep 2021	$6.17M	+22.6%
Jun 2021	$5.03M	+13.2%
Mar 2021	$4.45M	+22.4%
Dec 2020	$3.63M	+1.5%
Sep 2020	$3.58M	+5.0%
Jun 2020	$3.41M	+1.8%
Mar 2020	$3.35M	-34.1%
Dec 2019	$5.08M	+143.0%
Sep 2019	$2.09M	+2.7%
Jun 2019	$2.04M	+3.8%
Mar 2019	$1.96M	-59.9%
Dec 2018	$4.89M	+187.8%
Sep 2018	$1.70M	+111.2%
Jun 2018	$805.00K	+117.0%
Mar 2018	$371.00K	+7.5%
Dec 2017	$345.00K	+23.7%
Sep 2017	$279.00K	-1.1%
Jun 2017	$282.00K	+0.4%
Mar 2017	$281.00K	+13.3%
Dec 2016	$248.00K	-16.8%
Sep 2016	$298.00K	+31.3%
Jun 2016	$227.00K	-0.9%
Mar 2016	$229.00K	-33.2%
Dec 2015	$343.00K	-9.5%
Sep 2015	$379.00K	-2.1%
Jun 2015	$387.00K	+30.3%
Mar 2015	$297.00K	+147.7%
Dec 2014	-$623.00K	-132.4%
Sep 2014	$1.92M	+222.9%
Jun 2014	$595.00K	+19.5%
Mar 2014	$498.00K	-34.9%
Dec 2013	$765.00K	+1.5%
Sep 2013	$754.00K	-4.1%
Jun 2013	$786.00K	-6.7%

Month	Value	Change
Mar 2013	$842.00K	-48.8%
Dec 2012	$1.65M	+15.0%
Sep 2012	$1.43M	+1.7%
Jun 2012	$1.41M	+14.1%
Mar 2012	$1.23M	-31.0%
Dec 2011	$1.79M	+61.6%
Sep 2011	$1.11M	-44.7%
Jun 2011	$2.00M	+3.7%
Mar 2011	$1.93M	-14.9%
Dec 2010	$2.27M	-5.7%
Sep 2010	$2.40M	-14.2%
Jun 2010	$2.80M	-8.8%
Mar 2010	$3.07M	+1.2%
Dec 2009	$3.04M	-2.6%
Sep 2009	$3.12M	-1.2%
Jun 2009	$3.16M	-4.0%
Mar 2009	$3.29M	-3.5%
Dec 2008	$3.41M	+4.4%
Sep 2008	$3.26M	-1.1%
Jun 2008	$3.30M	+1.0%
Mar 2008	$3.26M	+3.7%
Dec 2007	$3.15M	+8.7%
Sep 2007	$2.90M	+18.0%
Jun 2007	$2.46M	-13.2%
Mar 2007	$2.83M	-21.9%
Dec 2006	$3.62M	-11.7%
Sep 2006	$4.10M	-10.8%
Jun 2006	$4.60M	+0.3%
Mar 2006	$4.59M	+4.5%
Dec 2005	$4.39M	-4.0%
Sep 2005	$4.57M	+5.0%
Jun 2005	$4.35M	-2.2%
Mar 2005	$4.45M	-0.0%
Dec 2004	$4.45M	+7.6%
Sep 2004	$4.14M	-3.0%
Jun 2004	$4.26M	-8.2%
Mar 2004	$4.64M	-8.3%
Dec 2003	$5.06M	+16.5%
Sep 2003	$4.35M	+3.3%
Jun 2003	$4.21M	+1.8%
Mar 2003	$4.13M	-31.5%
Dec 2002	$6.03M	+64.4%
Sep 2002	$3.67M	+2.0%
Jun 2002	$3.59M	+5.2%
Mar 2002	$3.42M	-22.4%
Dec 2001	$4.40M	+6.5%
Sep 2001	$4.13M	+6.4%
Jun 2001	$3.88M	+39.0%
Mar 2001	$2.79M	+54.5%
Dec 2000	$1.81M	+124.8%
Sep 2000	-$7.28M	-216.3%
Jun 2000	$6.26M	+54.7%
Mar 2000	$4.05M	-

FAQ

What is the current quarterly D&A of EXEL?: As of today, EXEL quarterly D&A is $6.98M
What is EXEL quarterly D&A most recent change?: EXEL quarterly D&A was up +0.52% on June 1, 2026
What is 1-year change in EXEL quarterly D&A?: EXEL quarterly D&A is down -4.88% year-over-year
How far is EXEL quarterly D&A from its all-time high?: EXEL quarterly D&A is currently -48.59% below its historical high of $13.59M set on March 31, 2023
How does EXEL quarterly D&A rank versus sector peers?: EXEL quarterly D&A is higher than 78.80% of companies in Healthcare sector
When is EXEL next earnings release?: The next earnings release for EXEL is on October 27, 2026

TTM D&A

$28.30M$358.00K-1.25%

June 1, 2026

Summary

Current Value: As of today, EXEL TTM D&A is $28.30M, down -1.25% on June 1, 2026
Historical Performance: EXEL TTM D&A is down -4.98% year-over-year, down -11.68% over the past 3 years
All-Time High Comparison: EXEL TTM D&A is currently -11.68% below its historical high of $32.04M set on June 30, 2023
3-Year Low Comparison: EXEL TTM D&A is +125.52% above its 3-year low of $12.55M reached on June 28, 2024
Sector Comparison: EXEL TTM D&A is higher than 79.31% of companies in Healthcare sector

Performance

EXEL Performance
Metric	Date	Value	3M	1Y	3Y	5Y
	Jun 1, 26	$28.30M	-1.3%	-5.0%	-11.7%	+69.5%
	Dec 1, 25	$29.06M	–	+0.9%	+39.2%	+108.0%
	Jun 1, 26	$6.98M	+0.5%	-4.9%	-47.5%	+38.8%
Price	Sep 17, 26	$58.49	+12.7%	+44.6%	+174.0%	+182.3%
	Jun 1, 26	-$661.22M	-226.9%	-227.6%	-230.3%	-278.0%
TTM Revenue	Jun 1, 26	$2.44B	+2.5%	+9.2%	+42.1%	+110.6%

TTM D&A Highs

EXEL TTM D&A Highs Comparison
Period	High	Date	Current
1Y	$29.75M	N/A	-4.9%
3Y	$32.04M	N/A	-11.7%
5Y	$32.04M	Jun 30, 23	-11.7%
All	$32.04M	Jun 30, 23	-11.7%

TTM D&A Lows

EXEL TTM D&A Lows Comparison
Period	Low	Date	Current
1Y	$28.30M	Jun 1, 26	at low
3Y	$12.55M	Jun 28, 24	+125.5%
5Y	$12.55M	Jun 28, 24	+125.5%
All	$440.00K	Sep 30, 15	+6331.8%

TTM D&A History

Month	Value	Change
Jun 2026	$28.30M	-1.2%
Mar 2026	$28.66M	-1.4%
Dec 2025	$29.06M	-2.3%
Sep 2025	$29.75M	-0.1%
Jun 2025	$29.78M	+0.0%
Mar 2025	$29.77M	+3.4%
Dec 2024	$28.80M	+4.0%
Sep 2024	$27.69M	+120.6%
Jun 2024	$12.55M	-32.2%
Mar 2024	$18.51M	-28.0%
Dec 2023	$25.72M	+94.7%
Sep 2023	$13.21M	-58.8%
Jun 2023	$32.04M	+12.1%
Mar 2023	$28.59M	+36.9%
Dec 2022	$20.88M	-30.8%
Sep 2022	$30.17M	+19.8%
Jun 2022	$25.19M	+23.5%
Mar 2022	$20.39M	+7.5%
Dec 2021	$18.96M	-1.7%
Sep 2021	$19.28M	+15.5%
Jun 2021	$16.69M	+10.8%
Mar 2021	$15.07M	+7.9%
Dec 2020	$13.97M	-9.4%
Sep 2020	$15.42M	+10.7%
Jun 2020	$13.93M	+10.9%
Mar 2020	$12.55M	+12.4%
Dec 2019	$11.17M	+1.7%
Sep 2019	$10.98M	+3.7%
Jun 2019	$10.59M	+13.2%
Mar 2019	$9.36M	+20.5%
Dec 2018	$7.77M	+141.2%
Sep 2018	$3.22M	+78.9%
Jun 2018	$1.80M	+41.0%
Mar 2018	$1.28M	+7.6%
Dec 2017	$1.19M	+8.9%
Sep 2017	$1.09M	-1.7%
Jun 2017	$1.11M	+5.2%
Mar 2017	$1.05M	+5.2%
Dec 2016	$1.00M	-8.7%
Sep 2016	$1.10M	-6.9%
Jun 2016	$1.18M	-12.0%
Mar 2016	$1.34M	-4.8%
Dec 2015	$1.41M	+219.5%
Sep 2015	$440.00K	-77.8%
Jun 2015	$1.98M	-9.5%
Mar 2015	$2.19M	-8.4%
Dec 2014	$2.39M	-36.7%
Sep 2014	$3.78M	+44.7%
Jun 2014	$2.61M	-6.8%
Mar 2014	$2.80M	-10.9%
Dec 2013	$3.15M	-21.9%
Sep 2013	$4.03M	-14.4%
Jun 2013	$4.71M	-11.7%

Month	Value	Change
Mar 2013	$5.33M	-6.8%
Dec 2012	$5.72M	-2.4%
Sep 2012	$5.86M	+5.9%
Jun 2012	$5.53M	-9.7%
Mar 2012	$6.13M	-10.2%
Dec 2011	$6.82M	-6.6%
Sep 2011	$7.30M	-15.1%
Jun 2011	$8.60M	-8.5%
Mar 2011	$9.40M	-10.8%
Dec 2010	$10.54M	-6.8%
Sep 2010	$11.31M	-5.9%
Jun 2010	$12.03M	-2.9%
Mar 2010	$12.38M	-1.7%
Dec 2009	$12.60M	-2.8%
Sep 2009	$12.96M	-1.1%
Jun 2009	$13.11M	-1.1%
Mar 2009	$13.25M	+0.2%
Dec 2008	$13.23M	+2.0%
Sep 2008	$12.97M	+2.9%
Jun 2008	$12.61M	+7.1%
Mar 2008	$11.77M	+3.8%
Dec 2007	$11.33M	-4.0%
Sep 2007	$11.81M	-9.3%
Jun 2007	$13.01M	-14.1%
Mar 2007	$15.15M	-10.4%
Dec 2006	$16.91M	-4.3%
Sep 2006	$17.67M	-2.6%
Jun 2006	$18.14M	+1.4%
Mar 2006	$17.89M	+0.8%
Dec 2005	$17.76M	-0.4%
Sep 2005	$17.82M	+2.5%
Jun 2005	$17.39M	+0.5%
Mar 2005	$17.30M	-1.1%
Dec 2004	$17.49M	-3.4%
Sep 2004	$18.11M	-1.2%
Jun 2004	$18.32M	+0.3%
Mar 2004	$18.26M	+2.9%
Dec 2003	$17.75M	-5.2%
Sep 2003	$18.71M	+3.8%
Jun 2003	$18.03M	+3.5%
Mar 2003	$17.42M	+4.3%
Dec 2002	$16.70M	+10.8%
Sep 2002	$15.08M	-3.0%
Jun 2002	$15.54M	-1.8%
Mar 2002	$15.83M	+4.1%
Dec 2001	$15.21M	+20.5%
Sep 2001	$12.62M	+947.0%
Jun 2001	$1.21M	-66.4%
Mar 2001	$3.58M	-25.9%
Dec 2000	$4.84M	+59.7%
Sep 2000	$3.03M	-70.6%
Jun 2000	$10.31M	+154.7%
Mar 2000	$4.05M	-

FAQ

What is the current TTM D&A of EXEL?: As of today, EXEL TTM D&A is $28.30M
What is EXEL TTM D&A most recent change?: EXEL TTM D&A was down -1.25% on June 1, 2026
What is 1-year change in EXEL TTM D&A?: EXEL TTM D&A is down -4.98% year-over-year
How far is EXEL TTM D&A from its all-time high?: EXEL TTM D&A is currently -11.68% below its historical high of $32.04M set on June 30, 2023
How does EXEL TTM D&A rank versus sector peers?: EXEL TTM D&A is higher than 79.31% of companies in Healthcare sector
When is EXEL next earnings release?: The next earnings release for EXEL is on October 27, 2026

Data Sources & References

EXEL Official Website www.exelixis.com
EXEL Profile on Yahoo Finance finance.yahoo.com/quote/EXEL
EXEL Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/exel